欧洲儿童急性肾脏替代治疗:EurAKId登记研究人口学结果
EurAKId前瞻性登记研究纳入0-18岁因急性肾损伤(AKI)或代谢紊乱、容量超负荷、脓毒症、呼吸窘迫接受腹膜透析、血液透析或连续肾脏替代治疗的患儿,分析340例患者数据,86%因AKI透析,84%在PICU治疗,最常用模式为CKRT(64%),总生存率65%,三种合并症患儿生存率显著低于无合并症者(41% vs 83%,P<0.001)。
要点
- 儿童急性透析以CKRT最常用(64%),其次为PD和HD(各14%)。
- 84%的儿童在PICU接受透析,总体生存率为65%。
- 三种合并症患儿生存率显著低于无合并症者(41% vs 83%,P<0.001)。
核心结论
- EurAKId登记是首个覆盖欧洲儿童重症与非重症急性肾脏替代治疗的前瞻性登记,显示患儿以危重症、男性为主,多在PICU接受CKRT。
- 儿童急性透析总体生存率65%,合并症数量与生存率显著相关。
研究设计与样本
- 前瞻性欧洲AKI登记(EurAKId registry,NCT02960867),纳入0-18岁接受PD、HD或CKRT治疗AKI或代谢紊乱、容量超负荷、脓毒症或呼吸窘迫的患儿。
- 共分析340例患者数据,定义5个年龄组和12类原发疾病。
主要发现
- 86%的患者因AKI接受透析,14%因非AKI原因;男孩占60%。
- 心脏和血液病患儿疾病严重程度高于肾脏病患儿。
- 84%的患者在PICU接受透析;最常用模式为CKRT(64%),PD和HD各占14%。
- 总体生存率65%;三种合并症患儿生存率41%,无合并症患儿83%(P<0.001)。
关键数值与推荐
- 三种合并症患儿生存率41%,无合并症患儿83%(P<0.001)。
临床怎么用
- 欧洲儿童急性透析以CKRT为主要模式,多用于PICU危重患儿。
- 合并症数量多的患儿生存率低,需关注心脏和血液病等重症患儿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute kidney injury (AKI), particularly that requiring dialysis, is a severe complication in hospitalized children that is associated with high morbidity and mortality. A prospective European AKI registry (EurAKId registry, NCT02960867) was created to describe the epidemiology and outcomes of paediatric patients treated with acute dialysis. METHODS: Children were recruited who were between 0 and 18 years of age and were treated both in and outside the paediatric intensive care unit (PICU) with peritoneal dialysis (PD), haemodialysis (HD) or continuous kidney replacement therapy (CKRT) for AKI or metabolic derangement, fluid overload (FO), sepsis or respiratory distress. Five age groups and 12 categories of primary diseases were defined. RESULTS: Data on 340 patients were analysed, of whom 86% received dialysis for AKI and 14% for reasons other than AKI. Boys accounted for 60% of the patients. Illness severity was greater in children with cardiac and haematologic diseases than those with kidney diseases. Most patients received dialysis in the PICU (84%). The most frequently used dialysis modality was CKRT (64%), followed by PD (14%) and HD (14%). The overall survival rate was 65%. Survival was significantly lower in children with three comorbidities than in children with no comorbidities (41% and 83%; P < 0.001). CONCLUSIONS: The EurAKId registry is the first prospective registry considering paediatric acute kidney replacement therapies (KRTs) in both critical and non-critical care settings, focusing on the three dialysis modalities in Europe. The clinical indications for KRT have expanded; our population was characterized by critically ill patients, primarily boys, who frequently received dialysis in the PICU with CKRT.
引用
- Guzzo I, de Galasso L, Bayazit AK, et al. Acute paediatric kidney replacement therapies in Europe: demographic results from the EurAKId Registry. Nephrol Dial Transplant. 2022. PMID: 34586417. doi:10.1093/ndt/gfab280
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。